Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005659700
Tue, 09.09.2025
Eckert & Ziegler SE
Berlin, 9 September 2025. Eckert & Ziegler SE (ISIN DE0005659700), a leading supplier of isotope technology components for nuclear medicine and measurement technology, will be rated by the Hamburg-based private bank Joh. Berenberg, Gossler & Co. KG from now on. In their initial study, the analysts issue a “Buy” recommendation with a price t [ … ]
Fri, 08.08.2025
Eckert & Ziegler SE
2nd Quarter 2025:
Sales: € 80.6 Mio. million (PY: € 77.8 million)
EBIT before special items: € 19.2 million (PY: € 17.5 million)
Net income: € 11,7 million (PY: € 9.5 million)
1st Half Year 2025:
Sales: € 148.8 million (PY: € 145.4 million)
EBIT before special items: € 35.4 million (PY: € 32.5 million)
Net income: € 21.4 million (PY: € 18.0 m [ … ]
Tue, 05.08.2025
Eckert & Ziegler SE
Berlin, 5 August 2025. All formal requirements of the stock split resolved by the Annual General Meeting on 18 June 2025 have now been met and the timeline for implementation of this capital measure of Eckert & Ziegler SE (ISIN DE0005659700) on the bank side is set.
Accordingly, the company's shareholders will be entitled to new shares in the r [ … ]
Tue, 29.07.2025
Eckert & Ziegler SE
Berlin, Germany, 29 July 2025. Eckert & Ziegler (ISIN DE0005659700) has entered a Master Service Agreement with Archeus Technologies (Archeus), a company developing multiple differentiated radiopharmaceutical therapies, for contract manufacturing of its novel investigational compound ART-101. The agreement supports Archeus’ upcoming Phase 1 cli [ … ]
Mon, 28.07.2025
Eckert & Ziegler SE
Berlin, July 28, 2025. The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) resolved on June 18, 2025, to increase the share capital using company funds by € 42,343,864 to € 63,515,796. The capital increase was entered in the commercial register on 25 July 2025 and thus became effective. As a result, the company's share capital [ … ]
Tue, 15.07.2025
Eckert & Ziegler SE
Berlin, July 15, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has been recognized by the Berlin Chamber of Industry and Commerce (IHK) for the exceptional quality of its training program for the fourth time in a row. The Berlin-based healthcare company already held the award for “Excellent Training Quality” from 2019 to 2020, from 2021 to 2023 [ … ]
Wed, 18.06.2025
Eckert & Ziegler SE
Berlin, June 18, 2025. The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of EUR 0.50 per share for the 2024 fiscal year.
As in the previous year, the Annual General Meeting was held as an in-person event at Eckert & Z [ … ]
Thu, 05.06.2025
Eckert & Ziegler SE
Berlin, Germany, 05 June 2025. Eckert & Ziegler (ISIN DE0005659700, TecDAX) congratulates Telix Pharmaceuticals Limited (Telix) on the approval of its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection) in Germany, where Eckert & Ziegler Radiopharma GmbH is the official distributor.
With [ … ]
Fri, 30.05.2025
Eckert & Ziegler SE
BOSTON, Mass., 30 May 2025. Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, underscoring its continued leadership in the radiopharmaceutical industry. Building upon the success of the previous editions, this year's event gathered around 100 decision makers, renowned experts, key partners, and influ [ … ]
Fri, 23.05.2025
Eckert & Ziegler SE
Berlin, May 23, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has once again been honored with the “Best Managed Companies Award”. The award, presented by Deloitte Private, UBS, the Frankfurter Allgemeine Zeitung and the Federation of German Industries (BDI), recognize excellently managed medium-sized companies throughout Germany. Eckert & [ … ]
